Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: Experience from the SEER database

Annals of Surgical Oncology

Volumn 17, Issue SUPPL. 3, 2010, Pages

  Yi, Min ^a   Giordano, Sharon Hermes ^a   Meric Bernstam, Funda ^a   Mittendorf, Elizabeth A ^a   Kuerer, Henry M ^a   Hwang, Rosa F ^a   Bedrosian, Isabelle ^a   Rourke, Loren ^a   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; SENTINEL LYMPH NODE BIOPSY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 78149265757     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1253-3     Document Type: Conference Paper

References (29)

1. K Benson AJ Hartz 2000 A comparison of observational studies and randomized, controlled trials Am J Ophthalmol 130 688 10.1016/S0002-9394(00) 00754-6 11078861
2. GH Lyman AE Giuliano MR Somerfield, et al. 2005 American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 7703 7720 10.1200/JCO.2005.08.001 16157938
3. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology: breast, version 2, 2008. http://www.nccn.org/professionals/ physiciangls/PDF/breast.pdf. Accessed on 1 Mar 2010.
4. JM Guenther NM Hansen LA DiFronzo, et al. 2003 Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes Arch Surg 138 52 56 10.1001/archsurg.138.1.52 12511150
5. JS Jeruss DJ Winchester SF Sener, et al. 2005 Axillary recurrence after sentinel node biopsy Ann Surg Oncol 12 34 40 10.1007/s10434-004-1164-2 15827776
6. KU Chu RR Turner NM Hansen, et al. 1999 Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 229 536 541 1:STN:280:DyaK1M3hslOgtQ%3D%3D 10.1097/00000658-199904000- 00013 10203087
7. RF Hwang AM Gonzalez-Angulo M Yi, et al. 2007 Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection Cancer 110 723 730 10.1002/cncr.22847 17587208
8. KJ Van Zee DM Manasseh JL Bevilacqua, et al. 2003 A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 1140 1151 10.1245/ASO.2003.03.015 14654469
9. JS Fant MD Grant SM Knox, et al. 2003 Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection Ann Surg Oncol 10 126 130 10.1245/ASO.2003.04.022 12620906
10. BJ Grube AE Giuliano 2001 Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial Semin Surg Oncol 20 230 237 1:STN:280:DC%2BD3MvnvFGhtw%3D%3D 10.1002/ssu.1038 11523108
11. MP Moore DW Kinne 1997 Axillary lymphadenectomy: a diagnostic and therapeutic procedure J Surg Oncol 66 2 6 1:STN:280:DyaK2svjs1Siug%3D%3D 10.1002/(SICI)1096-9098(199709)66:1<2::AID-JSO2>3.0.CO;2-8 9290685
12. ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1 or T2 N0 M0 breast cancer who have a positive sentinel node. https://www.acosog.org/studies/synopses/Z0011-Synopsis.pdf. Accessed on 1 Mar 2010.
13. ACOSOGZ0011 suspension of registration. https://www.acosog.org/ announcements/announcement-display.jsp?id=c0875d5e-062a-4901-ba65-926a7637c451. Accessed on 1 Mar 2010.
14. AM Leitch L McCall P Beitsch 2006 Factors influencing accrual to ACOSOG Z0011, a randomized phase III trial of axillary dissection vs observation for sentinel node positive breast cancer (abstract 601) J Clin Oncol 24 Suppl 28s
15. Giuliano AE, McCall L, Beitsch P, et al. Local and regional control in breast cancer after sentinel node biopsy without axillary lymph node dissection: results from a randomized trial. Paper presented at: American Surgical Association 130th annual meeting; 2010. http://www.americansurgical.info/ abstracts/2010/1.cgi.
16. KY Bilimoria DJ Bentrem NM Hansen, et al. 2009 Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 2946 2953 10.1200/JCO.2008.19.5750 19364968
17. MD Leggett SL Chen PD Schneider SR Martinez 2008 Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma Ann Surg Oncol 15 2493 2499 10.1245/s10434-008-0022-z 18594930
18. SR Martinez AS Robbins FJ Meyers, et al. 2008 Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma Cancer 112 1162 1168 10.1002/cncr.23261 18213619
19. SL Chen SR Martinez 2008 The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence Am J Surg 196 495 499 10.1016/j.amjsurg.2008.06.018 18809050
20. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2009. p. 223-40.
21. KM McMasters AE Giuliano MI Ross, et al. 1998 Sentinel-lymph-node biopsy for breast cancer-not yet the standard of care N Engl J Med 339 990 995 1:STN:280:DyaK1cvhvVKmsQ%3D%3D 10.1056/NEJM199810013391410 9753717
22. G Cserni D Gregori F Merletti, et al. 2004 Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer Br J Surg 91 1245 1252 1:STN:280:DC%2BD2cvpsFehtQ%3D%3D 10.1002/bjs.4725 15376203
23. A Katz BL Smith M Golshan, et al. 2008 Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer J Clin Oncol 26 2093 2098 10.1200/JCO.2007.11.9479 18445838
24. AM Naik J Fey M Gemignani, et al. 2004 The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures Ann Surg 240 462 468 10.1097/01.sla.0000137130.23530.19 15319717
25. Straver ME, Meijnen P, van Tienhoven G, et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol. 2010;28:731-7.
26. M Clarke R Collins S Darby, et al. 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 9503 2087 2106 1:STN:280:DC%2BD2MnnsVSitA%3D%3D 16360786
27. M Morrow 2009 Patterns of care with a positive sentinel node: echoes of an opportunity missed Ann Surg Oncol 16 2429 2430 10.1245/s10434-009-0552-z 19585172
28. J Concato N Shah RI Horwitz 2000 Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 1887 1892 1:STN:280:DC%2BD3czgt1Chsw%3D%3D 10.1056/NEJM200006223422507 10861325
29. DP Winchester L Trabanino MJ Lopez 2005 The evolution of surgery for breast cancer Surg Oncol Clin N Am 14 479 498 10.1016/j.soc.2005.04.006 15978425 vi.